ArticleNature communications2024

Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.

Sukanya Panja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.